Objective: Increased de novo fatty acid (FA) synthesis and cholesterol biosynthesis have been independently described in many tumour types, including hepatocellular carcinoma (HCC). Design: We investigated the functional contribution of fatty acid synthase (Fasn)-mediated de novo FA synthesis in a murine HCC model induced by loss of Pten and overexpression of c-Met (sgPten/c-Met) using liver-specific Fasn knockout mice. Expression arrays and lipidomic analysis were performed to characterise the global gene expression and lipid profiles, respectively, of sgPten/c-Met HCC from wild-type and Fasn knockout mice. Human HCC cell lines were used for in vitro studies. Results: Ablation of Fasn significantly delayed sgPten/c-Met-driven hepatocarcinogenesis in mice. However, eventually, HCC emerged in Fasn knockout mice. Comparative genomic and lipidomic analyses revealed the upregulation of genes involved in cholesterol biosynthesis, as well as decreased triglyceride levels and increased cholesterol esters, in HCC from these mice. Mechanistically, loss of Fasn promoted nuclear localisation and activation of sterol regulatory element binding protein 2 (Srebp2), which triggered cholesterogenesis. Blocking cholesterol synthesis via the dominant negative form of Srebp2 (dnSrebp2) completely prevented sgPten/c-Met-driven hepatocarcinogenesis in Fasn knockout mice. Similarly, silencing of FASN resulted in increased SREBP2 activation and hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (HMGCR) expression in human HCC cell lines. Concomitant inhibition of FASN-mediated FA synthesis and HMGCR-driven cholesterol production was highly detrimental for HCC cell growth in culture. Conclusion: Our study uncovers a novel functional crosstalk between aberrant lipogenesis and cholesterol biosynthesis pathways in hepatocarcinogenesis, whose concomitant inhibition might represent a therapeutic option for HCC.

Introduction Graziella Caselli and Marc Luy: Determinants of unusual and differential longevity Refereed Articles Elizabeth Wrigley-Field: Mortality deceleration is not informative of unobserved heterogeneity in open groups Shiro Horiuchi, Nadine Ouellette, Siu Lan Karen Cheung and Jean-Marie Robine: Modal age at death: lifespan indicator in the era of longevity extension Jon Anson: Surviving to be the oldest old—destiny or chance? Michel Poulain, Anne Herm and Gianni Pes: The Blue Zones: areas of exceptional longevity around the world Luis Rosero-Bixby, William H. Dow and David H. Rehkopf: The Nicoya region of Costa Rica: a high longevity island for elderly males Sebastian Kl?sener and Rembrandt D. Scholz: Regional hot spots of exceptional longevity in Germany Richard G. Rogers, Patrick M. Krueger, Richard Miech and Elizabeth M. Lawrence: Lifetime abstainers and mortality risk in the United States Maria Winkler-Dworak and Heiner Kaden: The longevity of academicians: evidence from the Saxonian Academy of Sciences and Humanities in Leipzig Morgan E. Levine and Eileen M. Crimmins: Evidence of resiliency among long-lived smokers Ethan J. Sharygin and Michel Guillot: Ethnicity, russification and excess mortality in Kazakhstan Graziella Caselli, Rosa Maria Lipsi, Enrica Lapucci and James W. Vaupel: Exploring Sardinian longevity: women fertility and parental transmission of longevity Val?rie Jarry, Alain Gagnon and Robert Bourbeau: Maternal age, birth order and other early-life factors: a family-level approach to exploring exceptional survival Leonid A. Gavrilov and Natalia S. Gavrilova: Determinants of exceptional human longevity: new ideas and findings Luisa Salaris, Nicola Tedesco and Michel Poulain: Familial transmission of human longevity: a population-based study in an inland village of Sardinia (Italy), 1850–2010